Fingerprint
Dive into the research topics of 'Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
Natalia Paez Arango, Erkan Yuca, Ming Zhao, Kurt W. Evans, Stephen Scott, Charissa Kim, Ana Maria Gonzalez-Angulo, Filip Janku, Naoto T. Ueno, Debu Tripathy, Argun Akcakanat, Aung Naing, Funda Meric-Bernstam
Research output: Contribution to journal › Article › peer-review
41
Scopus
citations